Naltrexone : une effet transitoire sur l'abstinence alcoolique, La Revue Prescrire, vol.18, issue.186, pp.483-488, 1998. ,
Vivitrex??, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats, Neuropsychopharmacology, vol.28, issue.11, pp.1973-82, 2003. ,
DOI : 10.1038/sj.npp.1300274
Sevrage en milieu hospitalier, Rev Prat, vol.49, issue.4, pp.387-90, 1999. ,
Risk for Delirium Tremens in Patients With Alcohol Withdrawal Syndrome, Substance Abuse, vol.23, issue.2, pp.83-94, 2002. ,
Le syndrome de sevrage d'alcool est une urgence dont le traitement a évolué, Rev Prat, vol.12, issue.431, pp.9-12, 1998. ,
Contribution of the opioid system to alcohol aversion and alcohol drinking behavior, J Pharmacol Exp Ther, vol.287, pp.284-92, 1998. ,
Repérage et diagnostic des malades de l'alcool, Rev Prat, vol.49, issue.4, pp.375-78, 1999. ,
Patients with alcohol problems, New Engl J Med, vol.339, p.130, 1998. ,
Les consommateurs d'alcool à problèmes, La Revue du Praticien, vol.49, issue.4, pp.379-82, 1999. ,
Oral topiramate for treatment of alcohol dependence: a randomised controlled trial, The Lancet, vol.361, issue.9370, pp.1677-1685, 2003. ,
DOI : 10.1016/S0140-6736(03)13370-3
Alcoolisme : complications psychiatriques aiguës et chroniques, Rev Prat, vol.44, issue.18, pp.421-425, 1994. ,
Efficacy and Safety of Aripiprazole in Alcohol Dependence, The American Journal of Drug and Alcohol Abuse, vol.113, issue.2, pp.393-401, 2007. ,
DOI : 10.1016/0021-9681(81)90058-8
Patients with Alcohol Problems, New England Journal of Medicine, vol.338, issue.9, pp.592-602, 1998. ,
DOI : 10.1056/NEJM199802263380907
Dysphagie due aux benzodiazépines, La Revue Prescrire, vol.19, pp.123-127, 0192. ,
Polytoxicomanie et traitement de substitution Usage et mésusage des benzodiazépines chez les usagers de drogues (1ère partie), Act. Med. Int. Psychiatrie, vol.203, issue.14, pp.3476-3483, 1997. ,
Polytoxicomanie et traitement de substitution Usage et mésusage des benzodiazépines chez les toxicomanes (2ème partie), Act. Med. Int. Psychiatrie, vol.203, issue.14, pp.3476-3483, 1997. ,
Les bases biologiques de la pharmacodépendance : les benzodiazépines, Rev Med Liege, vol.61, issue.5, pp.165-73, 1986. ,
Sevrage aux benzodiaz??pines des sujets d??pendants aux opiac??s en traitement de substitution, La Presse M??dicale, vol.35, issue.4, pp.599-606, 2006. ,
DOI : 10.1016/S0755-4982(06)74647-4
Les médicaments du sevrage des toxicomanies, Psychol Med, vol.21, issue.13, pp.2012-2018, 1989. ,
Dépendance aux benzodiazépines. Aspects cliniques et biologiques, Encephale, pp.147-57, 1994. ,
Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users, Clinical Pharmacokinetics, vol.33, issue.5, pp.344-400, 1997. ,
DOI : 10.2165/00003088-199733050-00003
Benzodiazépines : consommation au long cours et toxicomanie. Profil des consommateurs en milieu psychiatrique, Psychotropes, vol.7, issue.2, pp.55-65, 1992. ,
Efficacy and safety of herbal stimulants and sedatives in sleep disorders, Sleep Medicine Reviews, vol.4, issue.3, pp.229-251, 2000. ,
DOI : 10.1053/smrv.1999.0093
The Use of Herbal Alternative Medicines in Neuropsychiatry, The Journal of Neuropsychiatry and Clinical Neurosciences, vol.12, issue.2, pp.177-192, 2000. ,
DOI : 10.1176/jnp.12.2.177
Pharmacological effects of methamphetamine and other stimulants via inhalation exposure, Drug and Alcohol Dependence, vol.53, issue.2, pp.111-120, 1999. ,
DOI : 10.1016/S0376-8716(98)00120-3
Perinatal Cocaine and Methamphetamine Exposure, Obstetrical & Gynecological Survey, vol.43, issue.7, pp.571-579, 1987. ,
DOI : 10.1097/00006254-198807000-00011
Lung disease induced by drug addiction., Thorax, vol.50, issue.11, pp.1125-1132, 1995. ,
DOI : 10.1136/thx.50.11.1125
Intoxication aiguë par les opiacés, la cocaïne et l'ecstasy, Le Concours Medical, vol.120, issue.01, pp.24-31, 1998. ,
Medical Complications of Cocaine Abuse, New England Journal of Medicine, vol.315, issue.23, pp.1495-1500, 1986. ,
DOI : 10.1056/NEJM198612043152327
Prenatal Cocaine Exposure and Child Behavior, PEDIATRICS, vol.102, issue.4, pp.945-50, 1998. ,
DOI : 10.1542/peds.102.4.945
Development of a therapeutic vaccine for the treatment of cocaine addiction, Drug and Alcohol Dependence, vol.48, issue.3 ,
DOI : 10.1016/S0376-8716(97)00121-X
Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy, Drug and Alcohol Dependence, vol.48, issue.3, pp.159-65, 1997. ,
DOI : 10.1016/S0376-8716(97)00119-1
Cocaine-Induced Cerebral Vasoconstriction Detected in Humans With Magnetic Resonance Angiography, JAMA, vol.279, issue.5, pp.376-380, 1998. ,
DOI : 10.1001/jama.279.5.376
Ambient Temperature and Mortality From Unintentional Cocaine Overdose, JAMA, vol.279, issue.22, pp.1795-1800, 1998. ,
DOI : 10.1001/jama.279.22.1795
Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia, Drug and Alcohol Dependence, vol.82, issue.3, pp.238-249, 2006. ,
DOI : 10.1016/j.drugalcdep.2005.09.014
Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users, Clinical Pharmacokinetics, vol.33, issue.5, pp.344-400, 1997. ,
DOI : 10.2165/00003088-199733050-00003
Le crack : une forme de cocaïne inhale, Presse Med, vol.26, pp.1695-1698, 1997. ,
A role for mu opioid receptors in cocaine-induced activity, sensitization, and reward in the rat, Psychopharmacology, vol.2, issue.1, pp.265-272, 2007. ,
DOI : 10.1007/s00213-007-0883-z
Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine, Drug and Alcohol Dependence, vol.69, issue.3, pp.273-282, 2003. ,
DOI : 10.1016/S0376-8716(02)00328-9
Peripheral cocaine?blocking agents: new medication for Métabolisation hépatique 90% ,
Treating Tobacco Addiction ??? Nicotine or No Nicotine?, New England Journal of Medicine, vol.337, issue.17, pp.1230-1231, 1997. ,
DOI : 10.1056/NEJM199710233371710
Racial and Ethnic Differences in Serum Cotinine Levels of Cigarette Smokers, JAMA, vol.280, issue.2, pp.135-141, 1998. ,
DOI : 10.1001/jama.280.2.135
Tobacco dependence In : Psychopharmacology : the thrid generation of progress, 1987. ,
L'utilisation du tabac à chiquer, Une pratique émergente chez les adolescents, Presse Med, vol.34, pp.1145-1146, 2005. ,
Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study, The Lancet, vol.351, issue.9119, pp.1840-1843, 1998. ,
DOI : 10.1016/S0140-6736(97)07541-7
Pharmacokinetic and Pharmacodynamic Principles of Illicit Drug Use and Treatment of Illicit Drug Users, Clinical Pharmacokinetics, vol.33, issue.5, pp.344-400, 1997. ,
DOI : 10.2165/00003088-199733050-00003
Approche cognitivo?comportementale du traitemetn de l'alcoolodépendance, Rev Prat, vol.49, pp.395-404, 1999. ,
L'ecstasy et ses sosies, Presse Med, vol.285, issue.7, pp.358-62, 1997. ,
Low-dose MDMA (???ecstasy???) induces vasopressin secretion, The Lancet, vol.351, issue.9118, p.1784, 1998. ,
DOI : 10.1016/S0140-6736(05)78744-4
Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation, Pharmacology Biochemistry and Behavior, vol.81, issue.3 ,
DOI : 10.1016/j.pbb.2005.04.005
Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia, Psychopharmacology, vol.20, issue.1, pp.41-52, 2007. ,
DOI : 10.1007/s00213-007-0825-9
Ecstasy (MDMA) dependence, Drug and Alcohol Dependence, vol.53, issue.2, pp.121-124, 1999. ,
DOI : 10.1016/S0376-8716(98)00111-2
Toxicité de l'ecstasy, Presse Med, vol.26, issue.38, pp.1881-1885, 1997. ,
The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain, European Journal of Pharmacology, vol.559, issue.2-3, pp.132-137, 2007. ,
DOI : 10.1016/j.ejphar.2006.11.075
Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine, Drug and Alcohol Dependence, vol.81, pp.117-127, 2006. ,
Effets aigus et ?? long terme de l???ecstasy, La Presse M??dicale, vol.33, issue.18, pp.24-32, 2004. ,
DOI : 10.1016/S0755-4982(04)72379-9
A bitter pill. Overview of ecstasy ,
Communiqué de presse : Classement comme stupéfiant de la BZP, 2008. ,
Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, NZMJ, vol.118, pp.1-10, 1227. ,
Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP), 2007. ,
H2,5-Dimethoxyamphetamine-derived designer drugs: Studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6, Toxicol Lett, 2008. ,
Maternal marijuana use during lactation and infant development at one year, Neurotoxicology and Teratology, vol.12, issue.2, pp.161-169, 1990. ,
DOI : 10.1016/0892-0362(90)90129-Z
Marijuana withdrawal among adults seeking treatment for marijuana dependence, Addiction, vol.94, issue.9, pp.1311-1321, 1999. ,
DOI : 10.1046/j.1360-0443.1999.94913114.x
Données neurobiologiques récentes sur le cannabis, Bull Acad Nat Med, vol.186, issue.2, pp.319-329, 2002. ,
Neuropsychopharmacologie du delta-9-t??trahydrocannabinol (THC), Annales Pharmaceutiques Fran??aises, vol.66, issue.4, pp.219-231, 2008. ,
DOI : 10.1016/j.pharma.2008.07.003
Nouveau regard sur le cannabis URL : http://www.univrouen .fr/servlet/com.univ.utils.LectureFichierJoint?, pp.1106311066808-0, 2005. ,
Mesolimbic dopaminergic decline after cannabinoid withdrawal, Proceedings of the National Academy of Sciences, vol.95, issue.17, pp.10269-73, 1999. ,
DOI : 10.1073/pnas.95.17.10269
Adverse effects of cannabis, The Lancet, vol.352, issue.9140, pp.1611-1627, 1998. ,
DOI : 10.1016/S0140-6736(98)05021-1
Abstinence symptoms following smoked marijuana in humans, Psychopharmacology, vol.141, issue.4, pp.395-404, 1999. ,
DOI : 10.1007/s002130050849
Flashbacks: A personal follow-up, Archiv f???r Psychiatrie und Nervenkrankheiten, vol.92, issue.6, pp.293-304, 1976. ,
DOI : 10.1007/BF00343238
Artérite du cannabis versus maladie de Léo Buerger, Presse Med, vol.28, issue.2, pp.71-75, 1999. ,
Les troubles psychiatriques et somatiques induits par le cannabis, Annales Pharmaceutiques Fran??aises, vol.66, issue.4, pp.245-254, 2008. ,
DOI : 10.1016/j.pharma.2008.06.001
Addictions et psychiatrie, 2005. ,
Relapse in outpatient treatment for marijuana dependence ,
Cannabis et accidents de la voie publique : r??sultats des derni??res ??tudes fran??aises, Annales Pharmaceutiques Fran??aises, vol.64, issue.3, pp.192-196, 2006. ,
DOI : 10.1016/S0003-4509(06)75312-3
The endogenous cannabinoid system and the treatment of marijuana dependence, Neuropharmacology, vol.47, pp.359-367, 2004. ,
DOI : 10.1016/j.neuropharm.2004.07.018
Drug flashbacks II Some additionnal findings, International Journal, vol.11, issue.1, pp.53-69, 1976. ,
DOI : 10.3109/10826087109045530
Aspects médico?psychologiques de la consommation de cannabis, Rev Prat, vol.45, pp.1367-70, 1995. ,
Flashbacks among soldiers discharged as unfit who abused more than one drug, Am J Psychiatry, vol.140, issue.7, pp.857-61, 1983. ,
Candy -Dex -DM -DXM -Poor man's PCP -Red Devil -Robo -Rojo -Skittles -Triple C's -Tussin ? Velvet ,
sueurs nocturnes, myalgies, diarrhée, sensation de froid, agitation ,
Dextromethorphan Potentiates the Antinociceptive Effects of Morphine and the delta -Opioid Agonist SNC80 in Squirrel Monkeys, Journal of Pharmacology and Experimental Therapeutics, vol.300, issue.2, pp.435-441, 2002. ,
DOI : 10.1124/jpet.300.2.435
Dextromethorphan poisoning: An evidence-based consensus guideline for out-of-hospital management, Clinical Toxicology, vol.319, issue.6, pp.662-677, 2007. ,
DOI : 10.1097/00004583-199912000-00004
A randomized, double-blind, placebo-controlled safety study of high-dose dextromethorphan in methadone-maintained male inpatients, Drug and Alcohol Dependence, vol.67, issue.2, pp.177-183, 2002. ,
DOI : 10.1016/S0376-8716(02)00025-X
Discriminative stimulus properties of dextromethorphan in rats, Biomedicine & Pharmacotherapy, vol.49, issue.10, pp.456-64, 1995. ,
DOI : 10.1016/0753-3322(96)82690-4
Dextromethorphan antagonizes the acute depletion of brain serotonin by p-chloroamphetamine and H75/12 in rats, Brain Research, vol.594, issue.2, pp.323-329, 1992. ,
DOI : 10.1016/0006-8993(92)91144-4
Discriminative stimulus effects of dextromethorphan in the rat, Psychopharmacology, vol.206, issue.3 ,
DOI : 10.1007/BF02245325
Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats, Psychopharmacology, vol.172, pp.277-282, 2004. ,
Glutamate promotes proliferation of striatal neuronal progenitors by an NMDA receptor?mediated mechanism, J Neurosci, vol.23, issue.6, pp.2239-50, 2003. ,
Dextromethorphan psychosis, dependence and physical withdrawal, Addiction Biology, vol.15, issue.4, pp.325-327, 2005. ,
DOI : 10.1080/13556210500352410
Psychotropic Effects of Dextromethorphan Are Altered by the CYP2D6 Polymorphism, Journal of Clinical Psychopharmacology, vol.18, issue.4, pp.332-339, 1998. ,
DOI : 10.1097/00004714-199808000-00014
Side effects of dextromethorphan abuse, a case series, Addictive Behaviors, vol.30, issue.8, pp.1607-1613, 2005. ,
DOI : 10.1016/j.addbeh.2005.02.005
Over the counter psychotropics: a review of melatonin ,
Herbal Drugs of Abuse: An Emerging Problem, Emergency Medicine Clinics of North America, vol.25, issue.2, pp.435-457, 2005. ,
DOI : 10.1016/j.emc.2007.02.009
Blue acid - California sunshine -Chief -Cubes -D -Dome -Face melter -Flats - Frogs -Ghost -Green caps -Hawks -Hawaiian baby woodrose -Heavenly blue -Instant zen -La Souris Déglinguée -Lids -SD 25 -Lucy in the Sky with Diamonds -Microdot -Morning Glory -Orange wedges -Paper acid -Pearly gates -Pink drops -Purples wedges -Purpule haze -Royal blue -Sunshine -Wedding bells -Wedges -Window pane ,
que l'on retrouve dans la nature dans les graines d'Ipomoea violacea (Morning Glory) ,
abus existe, mais il est difficile d'évaluer le potentiel de dépendance du fait de la tolérance élevée ,
et parfois sniffé ou injecté en transcutanée. Surtout adolescents et jeunes adultes lors des fins de semaine ,
LSD-Like Panic From Risperidone in Post-LSD Visual Disorder, Journal of Clinical Psychopharmacology, vol.16, issue.3, pp.238-279, 1996. ,
DOI : 10.1097/00004714-199606000-00008
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors, Psychopharmacology, vol.22, issue.4, pp.401-410, 1995. ,
DOI : 10.1007/BF02245940
Herbal Drugs of Abuse: An Emerging Problem, Emergency Medicine Clinics of North America, vol.25, issue.2, pp.435-457, 2005. ,
DOI : 10.1016/j.emc.2007.02.009
diterpènes agonistes des récepteurs kappa opioïdes, Salvinorine A : la plus psychoactive, agoniste hautement sélectif des récepteurs kappa opioïdes qui serait équipotent à la dynorphine A, l'agoniste endogène, Seul hallucinogène non alcaloïde connu. Ce composé est le plus puissant hallucinogène naturel isolé à ce jour ,
Une étude a démontré une faible aversion pour les effets de salvinorine A chez les animaux, ce qui suggère que le complexe n'induirait pas de dépendance. Toutefois, aucun rapport n'existe actuellement dans la littérature sur la tolérance ,
La salvinorine A est efficace à des doses de 200-500 µg et produit des effets rapides et intenses en 5 à 6 min et qui durent 20 à 30 minutes, Alors que des doses de plus de 2 mg sont efficaces pour beaucoup plus longtemps ,
and Kratom, Clinical Toxicology, vol.198, issue.1, pp.146-152, 2008. ,
DOI : 10.1248/cpb.52.916
Hallucinatory and rewarding effect of salvinorin A in zebrafish: ??-opioid and CB1-cannabinoid receptor involvement, Psychopharmacology, vol.4, issue.4, pp.441-448, 2007. ,
DOI : 10.1007/s00213-006-0639-1
The pharmacological effects ofSalvia species on the central nervous system, Phytotherapy Research, vol.24, issue.6, pp.427-437, 2006. ,
DOI : 10.1002/ptr.1898
The antinociceptive effect of Salvinorin A in mice, European Journal of Pharmacology, vol.545, pp.129-133, 2006. ,
College student use of Salvia divinorum, Drug and Alcohol Dependence, vol.94, issue.1-3, pp.263-266, 2008. ,
DOI : 10.1016/j.drugalcdep.2007.10.018
Note d'information du 19 juillet Première identification du principe actif de la Salvia Divinorum dans SINTES, 2002. ,
Adolescent salvia substance abuse, Addiction, vol.43, issue.5, pp.823-824, 2007. ,
DOI : 10.1111/j.1360-0443.2007.01810.x
Internet access to Salvia divinorum: Implications for policy, prevention, and treatment, Journal of Substance Abuse Treatment, vol.35, issue.1, pp.22-27, 2007. ,
DOI : 10.1016/j.jsat.2007.07.011
Salvinorin A: From Natural Product to Human Therapeutics, Molecular Interventions, vol.6, issue.5, pp.257-265, 2006. ,
DOI : 10.1124/mi.6.5.7
The hallucinogen derived from Salvia divinorum, salvinorin A, has ??-opioid agonist discriminative stimulus effects in rats, Neuropharmacology, vol.53, issue.4, pp.481-486, 2007. ,
DOI : 10.1016/j.neuropharm.2007.06.008